Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CARA Cara Therapeutics Inc

0.00 (0.0%)
Dec 05 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cara Therapeutics Inc CARA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.02 18:41:45
Open Price Low Price High Price Close Price Prev Close
1.02 1.02 1.07 1.05 1.02
more quote information »

Recent News

Date Time Source Heading
12/05/20239:35IHNWFeaturedInternational Lithium: PEA for the Raleigh Lake Lithium Project Outlines Highly Favourable After-Tax NPV (Discounted at 8%) of CAD$342.9 million and After-Tax IRR of 44.3% P.A.
12/05/20237:30IHNWFeaturedProspera Energy Inc. Secures $3.5 Million in Development Financing and Announces Strategic Appointments to Strengthen Leadership Team
11/13/202316:28EDGAR2Form 8-K - Current report
11/13/202316:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202316:11EDGAR2Form 8-K - Current report
11/13/202316:01GLOBECara Therapeutics Reports Third Quarter 2023 Financial..
11/03/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202307:10EDGAR2Form 8-K - Current report
11/02/202307:00GLOBECara Therapeutics Announces up to $40.0 Million Non-Dilutive..
10/23/202307:00GLOBECara Therapeutics to Announce Third Quarter 2023 Financial..
9/25/202307:00GLOBECara Therapeutics Announces Approval of KORSUVA® IV..
9/05/202307:00GLOBECara Therapeutics to Present at the H.C. Wainwright 25th..
8/07/202316:24EDGAR2Form 8-K - Current report
8/07/202316:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:10EDGAR2Form 8-K - Current report
8/07/202316:01GLOBECara Therapeutics Reports Second Quarter 2023 Financial..
8/04/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/04/202317:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/04/202317:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/03/202307:06EDGAR2Form 8-K - Current report
8/03/202307:00GLOBECara Therapeutics Appoints Helen M. Boudreau to Board of..
8/02/202307:00GLOBECara Therapeutics to Present at the Canaccord Genuity 43rd..
7/25/202316:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
7/24/202307:00GLOBECara Therapeutics to Announce Second Quarter 2023 Financial..
6/02/202318:46PRNUSPalo Alto Networks Set to S&P 500; Others to Join S&P MidCap..
6/01/202307:00GLOBECara Therapeutics to Present at the Jefferies Healthcare..
5/18/202302:00GLOBEKapruvia® (difelikefalin) recommended by England’s NICE for..
5/15/202316:01GLOBECara Therapeutics Reports First Quarter 2023 Financial..
5/01/202307:00GLOBECara Therapeutics to Announce First Quarter 2023 Financial..
4/10/202307:00GLOBECara Therapeutics Announces Presentation at the 22nd Annual..
3/14/202307:00GLOBECara Therapeutics Releases Inaugural Environmental, Social,..
3/06/202316:01GLOBECara Therapeutics Announces Fourth Quarter and Full Year..
2/21/202307:00GLOBECara Therapeutics to Announce Fourth Quarter and Full Year..
2/08/202317:00GLOBECara Therapeutics Announces Results from the KOMFORT Phase 2..
1/17/202307:00GLOBECara Therapeutics to Host Capital Markets Day on Thursday,..
1/03/202307:00GLOBECara Therapeutics Announces Presentation at the 41st Annual..

Your Recent History

Delayed Upgrade Clock